Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,
Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs. However, the new study led by Ziyad Al-Aly, a physician-scientist at the Veterans Affairs St ...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight loss and ...
Study finds popular weight loss drugs may help with other health conditions
Obesity expert Dr. Naomi Parrella of Rush University joins Marie Saavedra to talk about the new study and the impact for patients.
Researchers reveal benefits, risks linked to popular weight-loss drugs
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity. Commonly marketed under brand names like Ozempic and Wegovy,
Yahoo10d
Weight loss options include lifestyle changes, GLP-1 drugs and surgery
GLP-1 drugs — like Ozempic ... Originally developed to treat diabetes, the drugs are now used for weight loss, too. The once-weekly injections are effective, Cauthen said, and patients ...
Yahoo Finance10d
GLP-1 weight loss medications pose challenges for c-stores. Here’s how retailers can respond.
GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites ... Another report from Circana found that GLP-1 users traditionally spent more at c-stores ...
An Ozempic alternative shows promising weight loss results — and Novo Nordisk stock surges 12%
Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...
Weight loss and the changing landscape of medical solutions | Real Men Wear Gowns
Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...